1-3 of 3
Paula Pera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antiproliferative and Proapoptotic Effect of Vitamin D in Bortezomib (B) Resistant Human Myeloma Cell Line (HMCL).

Asher Alban Chanan-Khan, MD, Michelle Romano, Paula Pera, Noreen Ersing, Josephia Muindi, MD, Donald L. Trump, MD, Candace Johnson, MD
Journal: Blood
Blood (2006) 108 (11): 5074.
https://doi.org/10.1182/blood.V108.11.5074.5074
Published: 2006
Journal Articles

Characterization of Bortezomib Resistant Human Multiple Myeloma Cell Line (HMCL): A Clinically Relevant Model for Novel Drug Development in Multiple Myeloma (MM).

Asher Alban Chanan-Khan, MD, Noreen Ersing, Paula Pera, Ralph Bernaki, Ph.D., Lionel Coignet, Ph.D., David W. Goodrich, Ph.D., Raya Haung, Ph.D., Carl W. Porter, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 5050.
https://doi.org/10.1182/blood.V108.11.5050.5050
Published: 2006
Journal Articles

In Vivo Evaluation of Immunomodulating Effects of Lenalidomide (L) on Tumor Cell Microenvironment as a Possible Underlying Mechanism of the Antitumor Effects Observed in Patients (pts) with Chronic Lymphocytic Leukemia (CLL).

Asher Alban Chanan-Khan, MD, Swaminathan Padmanabhan, MD, Kena C. Miller, NP, Paula Pera, Laurie DiMiceli, Noreen Ersing, Paul Wallace, MD, Michael Rickert, Carl Porter, MD
Journal: Blood
Blood (2005) 106 (11): 2975.
https://doi.org/10.1182/blood.V106.11.2975.2975
Published: 2005